' Clear Role ' for PARP Inhibitors in Advanced Ovarian Cancer ' Clear Role ' for PARP Inhibitors in Advanced Ovarian Cancer

Recent approval of rucaparib gives patients with ovarian cancer another new option for maintenance therapy.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news